相关实验视频

Updated: Mar 3, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

解读RPL38在肺腺癌中的作用:一种多omics方法

Lu Zhang^1,2,3, Fei Teng^1,2, Yuan Wang^1,2

¹Center of Thoracic Cancer, Chongqing University Caner Hospital, Chongqing, China.

Frontiers in immunology

|March 2, 2026

概括

核糖体蛋白L38 (RPL38) 促进肺腺癌 (LUAD) 的生长和免疫抑制瘤微环境. 针对RPL38可能为LUAD患者提供新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
基因组学就是基因组学.

背景情况:

核糖体蛋白L (RPL) 家族成员与癌症有关,但它们在肺腺癌 (LUAD) 中的特定作用尚未完全理解.
了解RPL基因的功能对于开发针对LUAD的向疗法至关重要.

研究的目的:

通过机器学习在LUAD中识别关键的RPL基因.
开发基于RPL基因表达的LUAD预测风险模型.
在LUAD中调查Ribosomal Protein L38 (RPL38) 的作用和预后意义.

主要方法:

机器学习分析了癌症基因组图谱 (TCGA) 的LUAD数据.
多omics分析,包括泛癌队列和空间转录组学.
在体外 (CCK-8,殖民地形成,伤口愈合,Transwell测定) 和体内 (皮下异种移植模型) 功能实验.

主要成果:

开发了一种基于RPL的三基因预后特征,识别高风险的LUAD患者的存活率较低和免疫抑制增加.
发现RPL38在包括LUAD在内的多种癌症上升调节,并与不良结果相关.
切除RPL38抑制了LUAD细胞的增殖,迁移和瘤生长,而空间转录学则将其表达与免疫抑制瘤微环境联系起来.

结论:

RPL38在LUAD中表现出促进瘤的作用.
这项研究阐明了RPL38对LUAD病原体的贡献.
RPL38为LUAD治疗提供了一个潜在的治疗点.

关键词:

在RPL38中使用RPL38.肺部腺癌的癌症.多主题数据数据多主题数据这是一个渐进的过程.瘤免疫免疫瘤免疫瘤微环境是一个微环境.

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...